The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial—study protocol for a randomized controlled trial

BACKGROUND: Septic shock remains a significant cause of death in critically ill patients. During septic shock, some patients will retain microcirculatory disorders despite optimal hemodynamic support (i.e., fluid resuscitation, vasopressors, inotropes). Alterations in the microcirculation are a key...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Trials
Main Authors: Legrand, Matthieu, Oufella, Hafid Ait, De Backer, Daniel, Duranteau, Jacques, Leone, Marc, Levy, Bruno, Rossignol, Patrick, Vicaut, Eric, Dépret, François
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7329442/
https://ncbi.nlm.nih.gov/pubmed/32611377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04549-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados